Marc Ullman was quoted in a NutraIngredients-USA article, “Indictment handed down in Florida over sale of SARMs, steroids.” Six people and two companies were charged by federal prosecutors for allegedly selling drugs unapproved by the FDA as supplements. “Some of these people seem to think, ‘What’s the worst that can happen to me? A warning letter? …
Read More

Robert Iseman penned a Thought Leaders Corner column for Population Health News in which he makes suggestions regarding how healthcare organizations can manage the social determinants of health (SDOH) within their patient population. Robert noted, among other things, “It is easy for a health system to get carried away in the world of SDOH. It is …
Read More

Cassandra Rivais was selected to serve as a reviewer for the abstracts of American Society of Bioethics and Humanities’ annual conference.  The organization hand-picks who will serve as reviewers, and reviewers get special recognition during the conference program. …
Read More

On April 2, Marc Ullman, along with the EAS Consulting Group, will conduct a Dietary Supplement GMP Seminar to help firms prepare for increased FDA enforcement. Given by former FDA compliance officials and industry experts, this intensive training program will provide all the information needed to comply with the rules, covering the responsibilities of domestic and …
Read More

On April 10, 2019, Marc Ullman and Steven Shapiro will be featured speakers at Supplyside East, presenting on the topic, “What Is the Regulatory Current State of Play with CBD?” The pair will discuss the latest insights around regulatory issues related to cannabidiol at the international, national and local levels. Supplyside East, which bills itself …
Read More

Dr. Scott Gottlieb, who announced his plan to resign as FDA commissioner on March 5, 2019, had in the previous week just announced plans to develop a regulatory framework for CBD. Marc Ullman spoke with Nutraingredients-USA about what might happen with the CBD initiative for the article entitled “Advocates hopeful that Gottlieb’s departure won’t derail …
Read More

Long Island Business News hosted a roundtable discussion on the current state of the healthcare industry. Rivkin partners Robert Iseman and Benjamin Malerba were joined by Dr. Zeyad Baker, ProHEALTH Care Associates’ president and CEO; Jeffrey Kraut, executive vice president of strategy and analytics at Northwell Health; and Dr. Simon Prince, president and CEO of …
Read More

Marc Ullman was quoted in a Nutraingredients-USA article, “Gottlieb: FDA plans meeting in April on new CBD regulations.” FDA Commissioner Scott Gottlieb said the agency is planning a public meeting in April to initiate a rule making procedure on CBD. Click here to read the article. …
Read More

Eric Fader weighed in on an article in Healthcare Risk Management discussing the HHS Office for Civil Rights’ request for information (RFI). The RFI seeks comment on how the HIPAA Privacy Rule might be changed to allow for better coordination of care among providers. Eric noted that the Treatment, Payment, and Healthcare Operations exception to …
Read More

Marc Ullman was quoted in a NutraIngredients-USA article, “Stakeholders cautiously optimistic on Gottlieb’s proposal for info protection in NDI filings.” The comments made by the FDA Commissioner Scott Gottlieb, MD, on the NDI’s issue have made dietary supplement industry stakeholders sit up and take notice. “I’m encouraged just in that it is good to hear …
Read More